{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:55:34Z","timestamp":1788270934578,"version":"build-2803163510"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1038\/s41433-024-03343-3","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T17:01:49Z","timestamp":1728666109000},"page":"870-882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Review of type 3 macular neovascularization in age-related macular degeneration: no DRAMA (Deep Retinal Age-related Microvascular Anomalies)"],"prefix":"10.1038","volume":"39","author":[{"given":"Livia","family":"Faes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Bijon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7477-2263","authenticated-orcid":false,"given":"Tommaso","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7888-9773","authenticated-orcid":false,"given":"K. Bailey","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"key":"3343_CR1","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1136\/bjophthalmol-2011-300344","volume":"95","author":"CA Curcio","year":"2011","unstructured":"Curcio CA, Johnson M, Rudolf M, Huang J-D. The oil spill in ageing Bruch membrane. Br J Ophthalmol 2011;95:1638\u201345.","journal-title":"Br J Ophthalmol"},{"key":"3343_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1001\/archopht.117.3.329","volume":"117","author":"CA Curcio","year":"1999","unstructured":"Curcio CA, Millican CL. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol 1999;117:329\u201339.","journal-title":"Arch Ophthalmol"},{"key":"3343_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.exer.2004.09.017","volume":"80","author":"CA Curcio","year":"2005","unstructured":"Curcio CA, Presley JB, Millican CL, Medeiros NE. Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. Exp Eye Res 2005;80:761\u201375.","journal-title":"Exp Eye Res"},{"key":"3343_CR4","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1001\/archopht.1995.01100120068012","volume":"113","author":"LP Aiello","year":"1995","unstructured":"Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995;113:1538\u201344.","journal-title":"Arch Ophthalmol"},{"key":"3343_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/00006982-200310000-00001","volume":"23","author":"RF Spaide","year":"2003","unstructured":"Spaide RF, Armstrong D, Browne R. Choroidal neovascularization in age-related macular degeneration\u2014what is the cause? Retina 2003;23:595.","journal-title":"Retina"},{"key":"3343_CR6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","volume":"127","author":"RF Spaide","year":"2020","unstructured":"Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, et al. Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group. Ophthalmology 2020;127:616\u201336.","journal-title":"Ophthalmology"},{"key":"3343_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.ophtha.2020.01.040","volume":"127","author":"L Chen","year":"2020","unstructured":"Chen L, Messinger JD, Sloan KR, Swain TA, Sugiura Y, Yannuzzi LA, et al. Nonexudative macular neovascularization supporting outer retina in age-related macular degeneration: a clinicopathologic correlation. Ophthalmology 2020;127:931\u201347.","journal-title":"Ophthalmology"},{"key":"3343_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/IAE.0b013e3181619c55","volume":"28","author":"LA Yannuzzi","year":"2008","unstructured":"Yannuzzi LA, Freund KB, Takahashi BS. Review of retinal angiomatous proliferation or type 3 neovascularization. Retina 2008;28:375\u201384.","journal-title":"Retina"},{"key":"3343_CR9","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ajo.2014.07.006","volume":"158","author":"JJ Jung","year":"2014","unstructured":"Jung JJ, Chen CY, Mrejen S, Gallego-Pinazo R, Xu L, Marsiglia M, et al. The incidence of neovascular subtypes in newly diagnosed neovascular age-related macular degeneration. Am J Ophthalmol 2014;158:769\u2013779.e2.","journal-title":"Am J Ophthalmol"},{"key":"3343_CR10","first-page":"2437","volume":"260","author":"KB Freund","year":"2022","unstructured":"Freund KB, Staurenghi G, Jung JJ, Zweifel SA, Cozzi M, Hill L, et al. Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR. Graefes Arch Clin Exp Ophthalmol 2022;260:2437\u201347.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3343_CR11","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S0161-6420(00)00009-9","volume":"107","author":"JS Slakter","year":"2000","unstructured":"Slakter JS, Yannuzzi LA, Schneider U, Sorenson JA, Ciardella A, Guyer DR, et al. Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 2000;107:742\u201353. discussion 753\u20134","journal-title":"Ophthalmology"},{"key":"3343_CR12","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/archopht.1995.01100110052025","volume":"113","author":"D Kuhn","year":"1995","unstructured":"Kuhn D, Meunier I, Soubrane G, Coscas G. Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments. Arch Ophthalmol 1995;113:1392\u20138.","journal-title":"Arch Ophthalmol"},{"key":"3343_CR13","first-page":"143","volume":"8","author":"Y Ohkuma","year":"2014","unstructured":"Ohkuma Y, Hayashi T, Sakai T, Watanabe A, Yamada H, Akahori M, et al. Retinal angiomatous proliferation associated with risk alleles of ARMS2\/HTRA1 gene polymorphisms in Japanese patients. Clin Ophthalmol 2014;8:143\u20138.","journal-title":"Clin Ophthalmol"},{"key":"3343_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/00006982-200509000-00005","volume":"25","author":"NE Gross","year":"2005","unstructured":"Gross NE, Aizman A, Brucker A, Klancnik JM Jr, Yannuzzi LA. Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina 2005;25:713\u20138.","journal-title":"Retina"},{"key":"3343_CR15","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1097\/IAE.0000000000003598","volume":"42","author":"R Sacconi","year":"2022","unstructured":"Sacconi R, Forte P, Capuano V, Miere A, Costanzo E, Tombolini B, et al. Optical coherence tomography angiography characterization of evolving lesions in fellow eyes of exudative type 3 macular neovascularization patients. Retina 2022;42:2075\u201382.","journal-title":"Retina"},{"key":"3343_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-10-31","volume":"10","author":"U Chakravarthy","year":"2010","unstructured":"Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010;10:31.","journal-title":"BMC Ophthalmol"},{"key":"3343_CR17","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1097\/IAE.0000000000001271","volume":"36","author":"X Chen","year":"2016","unstructured":"Chen X, Al-Sheikh M, Chan CK, Hariri AH, Abraham P, Lalezary M, et al. Type 1 versus type 3 neovascularization in pigment epithelial detachments associated with age-related macular degeneration after anti-vascular endothelial growth factor therapy: a prospective study. Retina 2016;36:S50\u2013S64.","journal-title":"Retina"},{"key":"3343_CR18","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/S0161-6420(96)30389-8","volume":"103","author":"ME Hartnett","year":"1996","unstructured":"Hartnett ME, Weiter JJ, Staurenghi G, Elsner AE. Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology 1996;103:2042\u201353.","journal-title":"Ophthalmology"},{"key":"3343_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/BF00166756","volume":"230","author":"ME Hartnett","year":"1992","unstructured":"Hartnett ME, Weiter JJ, Garsd A, Jalkh AE. Classification of retinal pigment epithelial detachments associated with drusen. Graefes Arch Clin Exp Ophthalmol. 1992;230:11\u201319.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3343_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/00006982-200110000-00003","volume":"21","author":"LA Yannuzzi","year":"2001","unstructured":"Yannuzzi LA, Negr\u00e3o S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001;21:416\u201334.","journal-title":"Retina"},{"key":"3343_CR21","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/00006982-200312000-00001","volume":"23","author":"JDM Gass","year":"2003","unstructured":"Gass JDM, Agarwal A, Lavina AM, Tawansy KA. Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina 2003;23:741\u201351.","journal-title":"Retina"},{"key":"3343_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/IAE.0b013e3181bceef0","volume":"30","author":"G Querques","year":"2010","unstructured":"Querques G, Atmani K, Berboucha E, Martinelli D, Coscas G, Soubrane G, et al. Angiographic analysis of retinal-choroidal anastomosis by confocal scanning laser ophthalmoscopy technology and corresponding (eye-tracked) spectral-domain optical coherence tomography. Retina 2010;30:222\u201334.","journal-title":"Retina"},{"key":"3343_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/IAE.0b013e3181669504","volume":"28","author":"KB Freund","year":"2008","unstructured":"Freund KB, Ho I-V, Barbazetto IA, Koizumi H, Laud K, Ferrara D, et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 2008;28:201\u201311.","journal-title":"Retina"},{"key":"3343_CR24","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/IAE.0b013e3181e7976b","volume":"30","author":"KB Freund","year":"2010","unstructured":"Freund KB, Zweifel SA, Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina 2010;30:1333\u201349.","journal-title":"Retina"},{"key":"3343_CR25","unstructured":"Gass JDM. Stereoscopic atlas of macular diseases: diagnosis and treatment, 4th ed. Mosby; Inc., St Louis 1998."},{"key":"3343_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/IAE.0b013e31805468fd","volume":"27","author":"SN Truong","year":"2007","unstructured":"Truong SN, Alam S, Zawadzki RJ, Choi SS, Telander DG, Park SS, et al. High resolution Fourier-domain optical coherence tomography of retinal angiomatous proliferation. Retina 2007;27:915\u201325.","journal-title":"Retina"},{"key":"3343_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00417-011-1804-8","volume":"250","author":"G Querques","year":"2012","unstructured":"Querques G, Avellis FO, Querques L, Massamba N, Bandello F, Souied EH. Three dimensional spectral domain optical coherence tomography features of retinal-choroidal anastomosis. Graefes Arch Clin Exp Ophthalmol 2012;250:165\u201373.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3343_CR28","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1097\/IAE.0b013e31827b639e","volume":"33","author":"G Querques","year":"2013","unstructured":"Querques G, Querques L, Forte R, Massamba N, Blanco R, Souied EH. Precursors of type 3 neovascularization: a multimodal imaging analysis. Retina 2013;33:1241\u20138.","journal-title":"Retina"},{"key":"3343_CR29","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1097\/IAE.0b013e3182923448","volume":"33","author":"G Querques","year":"2013","unstructured":"Querques G, Souied EH, Freund KB. Multimodal imaging of early stage 1 type 3 neovascularization with simultaneous eye-tracked spectral-domain optical coherence tomography and high-speed real-time angiography. Retina 2013;33:1881\u20137.","journal-title":"Retina"},{"key":"3343_CR30","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.oret.2018.04.016","volume":"2","author":"R Sacconi","year":"2018","unstructured":"Sacconi R, Sarraf D, Garrity S, Freund KB, Yannuzzi LA, Gal-Or O, et al. Nascent type 3 neovascularization in age-related macular degeneration. Ophthalmol Retin. 2018;2:1097\u2013106.","journal-title":"Ophthalmol Retin"},{"key":"3343_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/bjophthalmol-2020-316054","volume":"105","author":"R Sacconi","year":"2021","unstructured":"Sacconi R, Battista M, Borrelli E, Miere A, Corbelli E, Capuano V, et al. OCT-A characterisation of recurrent type 3 macular neovascularisation. Br J Ophthalmol 2021;105:222\u20136.","journal-title":"Br J Ophthalmol"},{"key":"3343_CR32","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1097\/IAE.0000000000001268","volume":"36","author":"D Su","year":"2016","unstructured":"Su D, Lin S, Phasukkijwatana N, Chen X, Tan A, Freund KB, et al. An updated staging system of type 3 neovascularization using spectral domain optical coherence tomography. Retina 2016;36:S40\u2013S49.","journal-title":"Retina"},{"key":"3343_CR33","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/IAE.0000000000000488","volume":"35","author":"A Nagiel","year":"2015","unstructured":"Nagiel A, Sarraf D, Sadda SR, Spaide RF, Jung JJ, Bhavsar KV, et al. Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography. Retina 2015;35:638\u201347.","journal-title":"Retina"},{"key":"3343_CR34","doi-asserted-by":"publisher","first-page":"100280","DOI":"10.1016\/j.xops.2023.100280","volume":"3","author":"A Berlin","year":"2023","unstructured":"Berlin A, Cabral D, Chen L, Messinger JD, Balaratnasingam C, Mendis R, et al. Histology of type 3 macular neovascularization and microvascular anomalies in treated age-related macular degeneration: a case study. Ophthalmol Sci. 2023;3:100280.","journal-title":"Ophthalmol Sci"},{"key":"3343_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ajo.2010.07.020","volume":"151","author":"ML Klein","year":"2011","unstructured":"Klein ML, Wilson DJ. Clinicopathologic correlation of choroidal and retinal neovascular lesions in age-related macular degeneration. Am J Ophthalmol 2011;151:161\u20139.","journal-title":"Am J Ophthalmol"},{"key":"3343_CR36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ophtha.2017.08.019","volume":"125","author":"M Li","year":"2018","unstructured":"Li M, Dolz-Marco R, Messinger JD, Wang L, Feist RM, Girkin CA, et al. Clinicopathologic correlation of anti\u2013vascular endothelial growth factor\u2013treated type 3 neovascularization in age-related macular degeneration. Ophthalmology 2018;125:276\u201387.","journal-title":"Ophthalmology"},{"key":"3343_CR37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1001\/jamaophthalmol.2022.0890","volume":"140","author":"A Berlin","year":"2022","unstructured":"Berlin A, Cabral D, Chen L, Messinger JD, Balaratnasingam C, Mendis R, et al. Correlation of optical coherence tomography angiography of type 3 macular neovascularization with corresponding histology. JAMA Ophthalmol. 2022;140:628\u201333.","journal-title":"JAMA Ophthalmol"},{"key":"3343_CR38","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/bjo.84.11.1269","volume":"84","author":"BA Lafaut","year":"2000","unstructured":"Lafaut BA, Aisenbrey S, Vanden Broecke C, Bartz-Schmidt KU. Clinicopathological correlation of deep retinal vascular anomalous complex in age related macular degeneration. Br J Ophthalmol. 2000;84:1269\u201374.","journal-title":"Br J Ophthalmol"},{"key":"3343_CR39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00417-006-0367-6","volume":"245","author":"H Shimada","year":"2007","unstructured":"Shimada H, Kawamura A, Mori R, Yuzawa M. Clinicopathological findings of retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol. 2007;245:295\u2013300.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3343_CR40","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1097\/IAE.0000000000002412","volume":"39","author":"RF Spaide","year":"2019","unstructured":"Spaide RF. New proposal for the pathophysiology of type 3 neovascularization as based on multimodal imaging findings. Retina 2019;39:1451\u201364.","journal-title":"Retina"},{"key":"3343_CR41","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.oret.2022.06.005","volume":"6","author":"D Cabral","year":"2022","unstructured":"Cabral D, Ramtohul P, Fradinho AC, Freund KB. Volume rendering of deep retinal age-related microvascular anomalies. Ophthalmol Retina. 2022;6:1185\u201393.","journal-title":"Ophthalmol Retina"},{"key":"3343_CR42","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1097\/IAE.0000000000000086","volume":"34","author":"T Yamazaki","year":"2014","unstructured":"Yamazaki T, Koizumi H, Yamagishi T, Kinoshita S. Subfoveal choroidal thickness in retinal angiomatous proliferation. Retina2014;34:1316\u201322.","journal-title":"Retina"},{"key":"3343_CR43","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1097\/IAE.0000000000002198","volume":"38","author":"E Borrelli","year":"2018","unstructured":"Borrelli E, Souied EH, Freund KB, Querques G, Miere A, Gal-Or O, et al. Reduced choriocapillaris flow in eyes with type 3 neovascularization and age-related macular degeneration. Retina 2018;38:1968\u201376.","journal-title":"Retina"},{"key":"3343_CR44","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00417-007-0705-3","volume":"246","author":"H Koizumi","year":"2008","unstructured":"Koizumi H, Iida T, Saito M, Nagayama D, Maruko I. Choroidal circulatory disturbances associated with retinal angiomatous proliferation on indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol 2008;246:515\u201320.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3343_CR45","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ajo.2012.11.001","volume":"155","author":"JH Kim","year":"2013","unstructured":"Kim JH, Kim JR, Kang SW, Kim SJ, Ha HS. Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration. Am J Ophthalmol 2013;155:743\u20139. 749.e1\u20132","journal-title":"Am J Ophthalmol"},{"key":"3343_CR46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.preteyeres.2010.09.003","volume":"30","author":"E Stef\u00e1nsson","year":"2011","unstructured":"Stef\u00e1nsson E, Geirsd\u00f3ttir A, Sigurdsson H. Metabolic physiology in age related macular degeneration. Prog Retin Eye Res 2011;30:72\u201380.","journal-title":"Prog Retin Eye Res"},{"key":"3343_CR47","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/archopht.123.11.1575","volume":"123","author":"B Mu\u00f1oz","year":"2005","unstructured":"Mu\u00f1oz B, Klein R, Rodriguez J, Snyder R, West SK. Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER. Arch Ophthalmol 2005;123:1575\u201380.","journal-title":"Arch Ophthalmol"},{"key":"3343_CR48","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1097\/IAE.0000000000002774","volume":"40","author":"B Haj Najeeb","year":"2020","unstructured":"Haj Najeeb B, Deak G, Schmidt-Erfurth U, Gerendas BS. The rap study, report two: the regional distribution of macular neovascularization type 3, a novel insight into its etiology. Retina 2020;40:2255\u201362.","journal-title":"Retina"},{"key":"3343_CR49","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrm1366","volume":"5","author":"CJ Schofield","year":"2004","unstructured":"Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004;5:343\u201354.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3343_CR50","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.yexcr.2009.03.019","volume":"315","author":"N Dehne","year":"2009","unstructured":"Dehne N, Br\u00fcne B. HIF-1 in the inflammatory microenvironment. Exp Cell Res 2009;315:1791\u20137.","journal-title":"Exp Cell Res"},{"key":"3343_CR51","first-page":"5995","volume":"59","author":"J-S Joyal","year":"2018","unstructured":"Joyal J-S. Retinal lipid and glucose metabolism dictates angiogenesis. Invest Ophthalmol Vis Sci 2018;59:5995\u20135995.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3343_CR52","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1097\/IAE.0000000000001672","volume":"37","author":"AH Skalet","year":"2017","unstructured":"Skalet AH, Miller AK, Klein ML, Lauer AK, Wilson DJ. Clinicopathologic correlation of retinal angiomatous proliferation treated with ranibizumab. Retina 2017;37:1620\u20134.","journal-title":"Retina"},{"key":"3343_CR53","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/00006982-200308000-00012","volume":"23","author":"JR Heckenlively","year":"2003","unstructured":"Heckenlively JR, Hawes NL, Friedlander M, Nusinowitz S, Hurd R, Davisson M, et al. Mouse model of subretinal neovascularization with choroidal anastomosis. Retina 2003;23:518\u201322.","journal-title":"Retina"},{"key":"3343_CR54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0021-9150(99)00068-4","volume":"145","author":"O Tiebel","year":"1999","unstructured":"Tiebel O, Oka K, Robinson K, Sullivan M, Martinez J, Nakamuta M, et al. Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation. Atherosclerosis 1999;145:239\u201351.","journal-title":"Atherosclerosis"},{"key":"3343_CR55","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1167\/iovs.10-6496","volume":"52","author":"J Hua","year":"2011","unstructured":"Hua J, Guerin KI, Chen J, Mich\u00e1n S, Stahl A, Krah NM, et al. Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-\/-) mice. Invest Ophthalmol Vis Sci 2011;52:2809\u201316.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3343_CR56","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0161-6420(02)01756-6","volume":"110","author":"RF Spaide","year":"2003","unstructured":"Spaide RF. Fundus autofluorescence and age-related macular degeneration. Ophthalmology 2003;110:392\u20139.","journal-title":"Ophthalmology"},{"key":"3343_CR57","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/IAE.0000000000001343","volume":"37","author":"ACS Tan","year":"2017","unstructured":"Tan ACS, Dansingani KK, Yannuzzi LA, Sarraf D, Freund KB. Type 3 neovascularization imaged with cross-sectional and en face optical coherence tomography angiography. Retina 2017;37:234\u201346.","journal-title":"Retina"},{"key":"3343_CR58","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.oret.2020.11.006","volume":"5","author":"L Chen","year":"2021","unstructured":"Chen L, Messinger JD, Ferrara D, Freund KB, Curcio CA. Stages of drusen-associated atrophy in age-related macular degeneration visible via histologically validated fundus autofluorescence. Ophthalmol Retin. 2021;5:730\u201342.","journal-title":"Ophthalmol Retin"},{"key":"3343_CR59","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00417-020-05021-y","volume":"259","author":"T Bacci","year":"2021","unstructured":"Bacci T, Essilfie JO, Leong BCS, Freund KB. Exudative non-neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2021;259:1123\u201334.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3343_CR60","doi-asserted-by":"publisher","first-page":"e00324","DOI":"10.7554\/eLife.00324","volume":"2","author":"L Luo","year":"2013","unstructured":"Luo L, Uehara H, Zhang X, Das SK, Olsen T, Holt D, et al. Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1. Elife 2013;2:e00324.","journal-title":"Elife"},{"key":"3343_CR61","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1097\/IAE.0000000000002182","volume":"38","author":"M Li","year":"2018","unstructured":"Li M, Huisingh C, Messinger J, Dolz-Marco R, Ferrara D, Freund KB, et al. Histology of geographic atrophy secondary to age-related macular degeneration: a multilayer approach. Retina 2018;38:1937\u201353.","journal-title":"Retina"},{"key":"3343_CR62","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41433-020-0896-y","volume":"35","author":"M Li","year":"2021","unstructured":"Li M, Dolz-Marco R, Messinger JD, Ferrara D, Freund KB, Curcio CA. Neurodegeneration, gliosis, and resolution of haemorrhage in neovascular age-related macular degeneration, a clinicopathologic correlation. Eye. 2021;35:548\u201358.","journal-title":"Eye"},{"key":"3343_CR63","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1097\/IAE.0000000000000835","volume":"35","author":"L Kuehlewein","year":"2015","unstructured":"Kuehlewein L, Dansingani KK, de Carlo TE, Bonini Filho MA, Iafe NA, Lenis TL, et al. Optical coherence tomography angiography of type 3 neovascularization secondary to age-related macular degeneration. Retina 2015;35:2229\u201335.","journal-title":"Retina"},{"key":"3343_CR64","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1097\/IAE.0000000000002892","volume":"40","author":"MP Breazzano","year":"2020","unstructured":"Breazzano MP, Bacci T, Curcio CA, Freund KB. Novel multimodal imaging and volume rendering of type 3 macular neovascularization. Retina 2020;40:e55\u2013e57.","journal-title":"Retina"},{"key":"3343_CR65","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/bjophthalmol-2016-308815","volume":"101","author":"N Phasukkijwatana","year":"2017","unstructured":"Phasukkijwatana N, Tan ACS, Chen X, Freund KB, Sarraf D. Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy. Br J Ophthalmol 2017;101:597\u2013602.","journal-title":"Br J Ophthalmol"},{"key":"3343_CR66","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.ophtha.2020.03.036","volume":"127","author":"T Bacci","year":"2020","unstructured":"Bacci T, Freund KB. High-resolution OCT angiography features of an early type 3 neovascularization. Ophthalmology 2020;127:887.","journal-title":"Ophthalmology"},{"key":"3343_CR67","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1097\/IAE.0000000000000834","volume":"35","author":"A Miere","year":"2015","unstructured":"Miere A, Querques G, Semoun O, El Ameen A, Capuano V, Souied EH. Optical coherence tomography angiography in early type 3 neovascularization. Retina 2015;35:2236\u201341.","journal-title":"Retina"},{"key":"3343_CR68","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1097\/IAE.0000000000001447","volume":"37","author":"A Miere","year":"2017","unstructured":"Miere A, Querques G, Semoun O, Amoroso F, Zambrowski O, Chapron T, et al. Optical coherence tomography angiography changes in early type 3 neovascularization after anti-vascular endothelial growth factor treatment. Retina 2017;37:1873\u20139.","journal-title":"Retina"},{"key":"3343_CR69","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/IAE.0000000000003261","volume":"42","author":"A Sharma","year":"2022","unstructured":"Sharma A, Cheung CMG, Arias-Barquet L, Ozdek S, Parachuri N, Kumar N, et al. Fluid-based visual prognostication in type 3 macular neovascularization-flip-3 study. Retina 2022;42:107\u201313.","journal-title":"Retina"},{"key":"3343_CR70","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.oret.2023.01.019","volume":"7","author":"R Sacconi","year":"2023","unstructured":"Sacconi R, Sarraf D, Sadda SR, Freund KB, Servillo A, Fogel Levin MM, et al. Nascent geographic atrophy as a predictor of type 3 macular neovascularization development. Ophthalmol Retin. 2023;7:586\u201392.","journal-title":"Ophthalmol Retin"},{"key":"3343_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53307-x","volume":"9","author":"E Borrelli","year":"2019","unstructured":"Borrelli E, Sacconi R, Klose G, de Sisternes L, Bandello F, Querques G. Rotational three-dimensional OCTA: a notable new imaging tool to characterize type 3 macular neovascularization. Sci Rep. 2019;9:17053.","journal-title":"Sci Rep."},{"key":"3343_CR72","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000089272","volume":"220","author":"MC Donati","year":"2006","unstructured":"Donati MC, Carifi G, Virgili G, Menchini U. Retinal angiomatous proliferation: association with clinical and angiographic features. Ophthalmologica 2006;220:31\u201336.","journal-title":"Ophthalmologica"},{"key":"3343_CR73","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/eye.2010.134","volume":"24","author":"AA Rouvas","year":"2010","unstructured":"Rouvas AA, Papakostas TD, Ntouraki A, Douvali M, Vergados I, Ladas ID. Angiographic and OCT features of retinal angiomatous proliferation. Eye. 2010;24:1633\u201342. quiz 1643","journal-title":"Eye"},{"key":"3343_CR74","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/IAE.0b013e3181a395cb","volume":"29","author":"F Viola","year":"2009","unstructured":"Viola F, Massacesi A, Orzalesi N, Ratiglia R, Staurenghi G. Retinal angiomatous proliferation: natural history and progression of visual loss. Retina 2009;29:732\u20139.","journal-title":"Retina"},{"key":"3343_CR75","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1001\/archopht.123.12.1644","volume":"123","author":"F Bottoni","year":"2005","unstructured":"Bottoni F, Massacesi A, Cigada M, Viola F, Musicco I, Staurenghi G. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 2005;123:1644\u201350.","journal-title":"Arch Ophthalmol"},{"key":"3343_CR76","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ophtha.2015.10.034","volume":"123","author":"E Daniel","year":"2016","unstructured":"Daniel E, Shaffer J, Ying G-S, Grunwald JE, Martin DF, Jaffe GJ, et al. Outcomes in eyes with retinal angiomatous proliferation in the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology 2016;123:609\u201316.","journal-title":"Ophthalmology"},{"key":"3343_CR77","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1097\/IAE.0b013e3181bfbd46","volume":"29","author":"M Engelbert","year":"2009","unstructured":"Engelbert M, Zweifel SA, Freund KB. \u2018Treat and extend\u2019 dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization\/retinal angiomatous proliferation. Retina 2009;29:1424\u201331.","journal-title":"Retina"},{"key":"3343_CR78","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/eye.2010.9","volume":"24","author":"K Atmani","year":"2010","unstructured":"Atmani K, Voigt M, Le Tien V, Querques G, Coscas G, Soubrane G, et al. Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration. Eye. 2010;24:1193\u20138.","journal-title":"Eye"},{"key":"3343_CR79","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/IAE.0000000000002562","volume":"40","author":"JW Han","year":"2020","unstructured":"Han JW, Cho HJ, Kang DH, Jung SH, Park S, Kim JW. Changes in optical coherence tomography angiography and disease activity in type 3 neovascularization after anti-vascular endothelial growth factor treatment. Retina 2020;40:1245\u201354.","journal-title":"Retina"},{"key":"3343_CR80","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.ajo.2015.08.028","volume":"160","author":"KK Dansingani","year":"2015","unstructured":"Dansingani KK, Balaratnasingam C, Klufas MA, Sarraf D, Freund KB. Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol 2015;160:1243\u20131254.e2.","journal-title":"Am J Ophthalmol"},{"key":"3343_CR81","doi-asserted-by":"publisher","unstructured":"Sepetis AE, Barbara R, Frisina R, Farag M, De Salvo G. Functional and structural characteristics in patients with type 3 macular neovascularisation treated with anti-VEGF. Three-year results in real world settings. Eye. 2024. https:\/\/doi.org\/10.1038\/s41433-023-02918-w.","DOI":"10.1038\/s41433-023-02918-w"},{"key":"3343_CR82","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s40123-022-00521-y","volume":"11","author":"Y-Y Huang","year":"2022","unstructured":"Huang Y-Y, Lo W-J, Chang H-Y, Chou Y-B, Lin T-C. Three-year outcomes of intravitreal aflibercept injections for retinal angiomatous proliferation according to disease stage. Ophthalmol Ther. 2022;11:1503\u201316.","journal-title":"Ophthalmol Ther"},{"key":"3343_CR83","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1097\/IAE.0000000000001876","volume":"38","author":"JH Kim","year":"2018","unstructured":"Kim JH, Chang YS, Kim JW, Kim CG, Lee DW, Cho SY. Difference in treatment outcomes according to optical coherence tomography-based stages in type 3 neovascularization (retinal angiomatous proliferation). Retina 2018;38:2356\u201362.","journal-title":"Retina"},{"key":"3343_CR84","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/eye.2010.88","volume":"24","author":"C Campa","year":"2010","unstructured":"Campa C, Harding SP, Pearce IA, Beare NAV, Briggs MC, Heimann H. Incidence of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Eye. 2010;24:1585\u20139.","journal-title":"Eye"},{"key":"3343_CR85","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/IAE.0b013e3181fe54c7","volume":"31","author":"VA McBain","year":"2011","unstructured":"McBain VA, Kumari R, Townend J, Lois N. Geographic atrophy in retinal angiomatous proliferation. Retina 2011;31:1043\u201352.","journal-title":"Retina"},{"key":"3343_CR86","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1097\/IAE.0000000000001862","volume":"38","author":"HJ Cho","year":"2018","unstructured":"Cho HJ, Hwang HJ, Kim HS, Han JI, Lee DW, Kim JW. Intravitreal aflibercept and ranibizumab injections for type 3 neovascularization. Retina 2018;38:2150\u20138.","journal-title":"Retina"},{"key":"3343_CR87","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/s41433-022-02249-2","volume":"37","author":"B Haj Najeeb","year":"2023","unstructured":"Haj Najeeb B, Schmidt-Erfurth U. Do patients with unilateral macular neovascularization type 3 need AREDS supplements to slow the progression to advanced age-related macular degeneration? Eye. 2023;37:1751\u20133.","journal-title":"Eye"},{"key":"3343_CR88","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ajo.2014.10.035","volume":"159","author":"HJ Cho","year":"2015","unstructured":"Cho HJ, Yoo SG, Kim HS, Kim JH, Kim CG, Lee TG, et al. Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation. Am J Ophthalmol 2015;159:285\u201392.e1.","journal-title":"Am J Ophthalmol"},{"key":"3343_CR89","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1167\/iovs.13-12284","volume":"54","author":"JY Lee","year":"2013","unstructured":"Lee JY, Lee DH, Lee JY, Yoon YH. Correlation between subfoveal choroidal thickness and the severity or progression of nonexudative age-related macular degeneration. Invest Ophthalmol Vis Sci 2013;54:7812\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3343_CR90","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.2147\/OPTH.S130165","volume":"11","author":"A Rabiolo","year":"2017","unstructured":"Rabiolo A, Sacconi R, Cicinelli MV, Querques L, Bandello F, Querques G. Spotlight on reticular pseudodrusen. Clin Ophthalmol 2017;11:1707\u201318.","journal-title":"Clin Ophthalmol"},{"key":"3343_CR91","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.oret.2022.02.010","volume":"6","author":"R Sacconi","year":"2022","unstructured":"Sacconi R, Forte P, Tombolini B, Grosso D, Fantaguzzi F, Pina A, et al. OCT predictors of 3-year visual outcome for type 3 macular neovascularization. Ophthalmol Retin. 2022;6:586\u201394.","journal-title":"Ophthalmol Retin"},{"key":"3343_CR92","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1755-3768.2011.02265.x","volume":"91","author":"MB Parodi","year":"2013","unstructured":"Parodi MB, Iacono P, Menchini F, Sheth S, Polini G, Pittino R, et al. Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation. Acta Ophthalmol. 2013;91:267\u201373.","journal-title":"Acta Ophthalmol"},{"key":"3343_CR93","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00417-015-2993-3","volume":"254","author":"HJ Cho","year":"2016","unstructured":"Cho HJ, Lee TG, Han SY, Kim HS, Kim JH, Han JI, et al. Long-term visual outcome and prognostic factors of Intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2016;254:23\u201330.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3343_CR94","first-page":"1165","volume":"247","author":"L Konstantinidis","year":"2009","unstructured":"Konstantinidis L, Mameletzi E, Mantel I, Pournaras J-A, Zografos L, Ambresin A. Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP). Arbeitsphysiologie 2009;247:1165\u201371.","journal-title":"Arbeitsphysiologie"},{"key":"3343_CR95","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.oret.2022.10.004","volume":"7","author":"I Zucchiatti","year":"2023","unstructured":"Zucchiatti I, Sacconi R, Querques G. Re: Cabral et al: Volume rendering of deep retinal age-related microvascular anomalies. Ophthalmol Retina 2023;7:e3.","journal-title":"Ophthalmol Retina"},{"key":"3343_CR96","doi-asserted-by":"publisher","first-page":"559.e1","DOI":"10.1016\/j.jfo.2011.03.002","volume":"34","author":"G Querques","year":"2011","unstructured":"Querques G, Kuhn D, Massamba N, Leveziel N, Querques L, Souied EH. Perifoveal exudative vascular anomalous complex. J Fr Ophtalmol 2011;34:559.e1\u20134.","journal-title":"J Fr Ophtalmol"},{"key":"3343_CR97","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ajo.2017.10.009","volume":"184","author":"R Sacconi","year":"2017","unstructured":"Sacconi R, Freund KB, Yannuzzi LA, Dolz-Marco R, Souied E, Capuano V, et al. The expanded spectrum of perifoveal exudative vascular anomalous complex. Am J Ophthalmol 2017;184:137\u201346.","journal-title":"Am J Ophthalmol"},{"key":"3343_CR98","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/IAE.0000000000002435","volume":"40","author":"S Mrejen","year":"2020","unstructured":"Mrejen S, Le HM, Nghiem-Buffet S, Tabary S, Quentel G, Cohen SY. Insights into perifoveal exudative vascular anomalous complex. Retina 2020;40:80\u201386.","journal-title":"Retina"},{"key":"3343_CR99","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ajo.2010.02.019","volume":"150","author":"SY Cohen","year":"2010","unstructured":"Cohen SY, Dubois L, Nghiem-Buffet S, Ayrault S, Fajnkuchen F, Guiberteau B, et al. Retinal pseudocysts in age-related geographic atrophy. Am J Ophthalmol 2010;150:211\u2013217.e1.","journal-title":"Am J Ophthalmol"},{"key":"3343_CR100","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.preteyeres.2017.01.003","volume":"58","author":"RA Linsenmeier","year":"2017","unstructured":"Linsenmeier RA, Zhang HF. Retinal oxygen: from animals to humans. Prog Retina Eye Res 2017;58:115\u201351.","journal-title":"Prog Retina Eye Res"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03343-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T09:36:59Z","timestamp":1742981819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03343-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3343"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-03343-3","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]},"assertion":[{"value":"15 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.Faes is a member of the Eye editorial board and has no financial disclosures. K.B. Freund is a consultant for Heidelberg Engineering, Zeiss, Genentech, Bayer, Novartis, and Allergan. He receives research support from Genentech\/Roche. The authors declare that there is no conflict of interest regarding the publication of this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}